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The complete DNA sequence of human herpesvirus-7 (HHV-7) strain RK was determined following direct cloning of virion
DNA fragments into a sequencing vector. The sequence was compared with the previously published complete sequences
of HHV-7 strain JI and human herpesvirus-6 (HHV-6) strain U1102. Despite a very close relationship between the two HHV-7
strains, differences are apparent in regions containing tandem reiterations, particularly in the ‘‘telomeric’’ reiterations located
near the termini of the large direct repeat at the genome ends, and in a total of 179 additional positions distributed throughout
the genome (i.e., about one nucleotide difference per kbp). This extent of divergence implies that the two strains arose from
an ancestral virus several thousands of years ago. Differences that affect coding potential do not cluster in particular
protein-coding regions, indicating that specific HHV-7 genes have not been measurably subject to unusual evolutionary
pressures since divergence. Reassessments of genetic content indicated that the HHV-7 genome contains 84 different
genes, whereas the HHV-6 genome contains 85. All HHV-7 genes but 1 have direct HHV-6 counterparts, and all but 2 HHV-6
genes have HHV-7 homologues. Sequence comparisons between HHV-7 and HHV-6 provided evidence that the protein-
coding regions of 11 genes are expressed by splicing. © 1998 Academic Press
INTRODUCTION
Human herpesvirus-7 (HHV-7) was first isolated in
1989 at the National Institutes of Health (Bethesda, MD)
by Frenkel et al. (1990) after activation of CD41 T cells
purified from the peripheral blood of a healthy individual
(initials RK). This isolate was designated HHV-7(RK), fol-
lowing the rules of the Herpesvirus Study Group of the
ICTV (Roizman et al., 1981). The virus was shown to be
related to the two variants of human herpesvirus-6
(HHV-6A and -6B) by DNA hybridization, and yet exhib-
ited restriction endonuclease patterns that are distinct
from those of both variants. Subsequently, other strains
were isolated, including HHV-7(JI), which was obtained
by Berneman et al. (1992b) at the National Cancer Insti-
tute (Bethesda, MD) from the peripheral blood mononu-
clear cells of a patient suffering from chronic fatigue
syndrome. Initial DNA sequence data from HHV-7(JI) re-
inforced the view that HHV-7 and HHV-6 are closely
related but distinct members of the Betaherpesvirinae
(Berneman et al., 1992a). HHV-6 and HHV-7 are ubiqui-
tous in the human population (Okuno et al., 1989; Wyatt et
al., 1991), and one of the HHV-6 variants (HHV-6B) has
been proposed as the causative agent of a childhood
disease, exanthem subitum (Yamanishi et al., 1988).
HHV-7 has no proven involvement in any disease. A
potential role in a proportion of exanthem subitum cases
has been suggested (Tanaka et al., 1994).
The genome sequence of HHV-7(JI) was derived by
Nicholas (1996) from plasmid and bacteriophage l
clones. It yielded a detailed picture of the organization of
HHV-7 genes and their relationships to genes of other
sequenced herpesviruses, particularly HHV-6A strain
U1102 (Gompels et al., 1995) and human cytomegalovirus
(HCMV) strain AD169 (Chee et al., 1990). The HHV-7(JI)
genome is 144,861 bp in size, and consists of a unique
region (U) of 133,233 bp flanked by a large direct repeat
(DR) of 5814 bp. A total of 101 open reading frames
(ORFs) potentially encoding proteins were identified, 8 of
them present in both copies of DR. Of these, 11 lack
counterparts in HHV-6.
The HHV-6A(U1102) genome is 159,321 bp in size and
has a similar structure to that of HHV-7, U and DR being
143,147 and 8087 bp in size, respectively. Of the 113 ORFs
(8 present in both copies of DR) listed by Gompels et al.
(1995), 22 lack counterparts in HHV-7(JI). Taking into
account possible splicing and excluding some ORFs
thought unlikely to encode proteins, the HHV-6 genome
was considered to contain 102 separate genes. The
majority of HHV-6 (and HHV-7) genes have counterparts
in HCMV, and about 40 have counterparts in all se-
quenced mammalian herpesviruses.
In this paper, we report the complete DNA sequence
of HHV-7(RK). We present reassessments of the genetic
contents of HHV-7 and HHV-6 derived by comparing the
HHV-7(RK), HHV-7(JI), and HHV-6A(U1102) sequences.
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Evidence for splicing in several genes is of special in-
terest. Readers should note that these studies build on
the extensive sequence interpretations of Gompels et al.
(1995) and Nicholas (1996), and reference to these anal-
yses is implicit throughout this paper. Also, we have
used citations sparingly, since very extensive bibliogra-
phies were provided in these earlier publications.
RESULTS AND DISCUSSION
Viral origin of the sequenced DNA
HHV-7(RK) genomic DNA was isolated from capsids
on the principle that encapsidated viral DNA, unlike cel-
lular or nonencapsidated viral DNA, is protected from
digestion by DNase I. As the sequencing protocol was
based on alignment of the sequences of a large number
of random fragments generated by sonication of this
DNA, it was important to verify the purity of the prepara-
tions (data not shown). Each of the four preparations
analysed was found to contain a few micrograms of
genome-length DNA plus a much larger amount of frag-
ments smaller than genome size (up to several kbp) or
100 bp, or both. The provenance of these fragments was
not determined, and they may represent residual viral or
cellular DNA that was degraded during DNase digestion
but remained associated with capsids.
Genome-length DNA was selectively precipitated us-
ing polyethylene glycol from a DNA preparation that was
heavily contaminated with fragments smaller than 100
bp. The proportion of random sequences obtained using
this material that contributed to the final genomic se-
quence indicated that the 97% originated from the RK
genome.
Genome features
The final database obtained by entry of all random
sequences was edited by careful reference to autoradio-
graphs. The sequence was determined an average of 8.2
times per nucleotide, and 97% was determined on both
strands. Regions in which data were obtained for only
one strand were examined particularly closely during
editing. Ambiguities throughout the sequence were then
resolved by analyses of specific templates from both
strands using the universal or custom primers. At this
stage, the RK sequence was compared with the pub-
lished sequence of HHV-7(JI). Positions at which the RK
sequence differed from that of JI were checked by refer-
ence to autoradiographs, and confirmatory data were
obtained when necessary.
Sequences containing the genome termini were iden-
tified in the database inasmuch as they have one unique
end, unlike other fragments generated randomly from the
genome. Most clones from the left terminus ended in six
C residues, but the possibility of heterogeneity was sug-
gested by the presence of fewer C residues in some
clones. As fragments were end-repaired prior to ligation,
no information was obtained on unpaired nucleotides at
the termini. The genome termini of another HHV-7 strain
(R-2), also sequenced from end-repaired DNA, are iden-
tical (Secchiero et al., 1995). Sequences at the termini of
JI have not been determined directly. However, concate-
meric DNA from HHV-7-infected cells contains head-to-
tail copies of the genome, and the DR–DR junction thus
corresponds to a fused version of the termini (including
any unpaired residues normally present at the termini).
The sequence of this region in JI concatemers is vari-
able, containing four to six C residues in the region
corresponding to the left terminus plus, in some in-
stances, one or two additional nucleotides at the junction
itself (Secchiero et al., 1995). Again, this suggests that
the tract of C residues at the left terminus is variable in
length. The right terminus of the published JI genome
sequence is identical to that of RK, but the left terminus
is one base pair longer, containing seven C residues.
The origin of this additional residue is unclear.
No evidence was obtained from the random sequence
data to indicate that there are any differences between
the two copies of DR (also termed TR by Frenkel and
Roffman (1996)). As a consequence, the final database
contained only one copy. Sequences at the genome
termini were used to identify the DR–U and U–DR junc-
tions and thus to define the DR sequence. The genome
sequence was reconstructed to represent U (133,012 bp)
flanked on each side by a copy of DR (10,034 bp). The
total size of the sequence is, therefore, 153,080 bp.
Strain variation
Four regions in the RK genome contain head-to-tail
reiterations of short sequence elements. Their locations
are shown in Fig. 1. Two (R1 and R2) are located in U, and
two (telomeric reiterations T1 and T2) are located near
the ends of DR. Reiterations are located at similar posi-
tions in JI, but each is different in size and sequence to
its RK counterpart. In RK, R1 comprises three copies of
an 84-bp element and a partial copy of 68 bp, with two
mismatched nucleotides. In JI, the third copy of the ele-
ment is only 81 bp long, differing from the other two
elements in several positions, and the partial copy is
shorter (66 bp). R2 consists of an array of related 105-bp
elements. RK has 15 copies plus a partial copy of 26 bp,
and JI has 17 copies plus the partial copy. The RK and JI
sequences are similar towards the ends of the array, but
differ in the central region.
The basic element of T1 and T2 (TAACCC) is related to
human telomeric sequences. These reiterations consist
of arrays of this element interspersed with 34 types of
related elements, most also hexanucleotides but some
larger. Sequences for these regions were derived from
the random sequence data with difficulty. The range of
different element types aided the analysis, but their pres-
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ence at two separate loci was a complicating factor. An
acceptable solution for T2 was obtained, but that for T1
was ultimately unsatisfactory, as described below. The
large size and reiterated structure of T1 preempted se-
quencing it from single templates using the universal or
custom primers.
FIG. 1. Predicted HHV-7 gene arrangement. The genome is shaded, the thinner and thicker portions denoting the unique region and terminal direct
repeats, respectively. The scale is in kbp. Protein-coding regions (DR1, DR6, U2-U100) are shown as open arrows above the gene nomenclature; the
U prefix has been omitted. ORFs predicted to be expressed as spliced mRNAs are connected by open horizontal bars. Candidate polyadenylation
signals (AATAAA, ATTAAA, or AGTAAA) are indicated by vertical arrows in the appropriate strand. Reiterated sequences (R1, R2, T1, and T2) are shown
as filled rectangles above the genome. The minimal fragment shown to act as an origin of DNA replication (ori) is indicated (van Loon et al., 1997).
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T2 is the shorter reiteration, consisting of 148 copies of
the telomeric element. The BamHI fragment at the right
genome terminus contains T2, and a close correspon-
dence in size is evident between the RK fragment pre-
dicted from the sequence (3811 bp) and that detected in
genomic DNA by DNA hybridization (3.8 kbp; Singer and
Frenkel, 1997).
The solution derived for T1 contains 663 copies of the
telomeric element. It is probably incorrect, however,
since the size of the predominant BamHI fragment iden-
tified by DNA hybridization at the left terminus of
genomic DNA is 1.7 kbp smaller than that predicted from
the sequence (Singer and Frenkel, 1997). Moreover, a
few random fragments could not be accommodated in
the deduced sequence. This may reflect either the in-
tractability of this region or sequence heterogeneity oc-
curring in the genome or in M13 recombinants. Variability
in the genome itself is supported by the observation that
the terminal BamHI fragment identified by Singer and
Frenkel (1997) is heterogeneous in size. Therefore, it
must be emphasized that although the size of the RK
genome as derived from the sequence is 153,080 bp, the
actual size of the major species is likely to be a little less
than 150 kbp.
Bacterial clones containing T1 and T2 from JI contain
20 and 106 copies of the telomeric element, respectively
(Secchiero et al., 1995). Both are thus smaller than in RK,
the former markedly so. The corresponding sequences
in JI genomic DNA are likely to be different, however,
since they vary in size in different plasmid clones (Ruvulo
et al., 1996). In support of the view that HHV-7 does not
have a unique genome size, we note that Frenkel and
Roffman (1996) reported that the genomes of different
HHV-7 strains range in size from 140 to 150 kbp, and
suggested that the main cause of variation involves the
telomeric reiterations.
The presence of telomeric reiterations in the HHV-7
and HHV-6 genomes is of unknown significance. Pub-
lished speculations include roles in genome cleavage,
regulation of gene expression, segregation during cell
division, latent-phase viral DNA replication, and site-
specific recombination into the host genome. Whatever
their function, if any, it appears that the telomeric reiter-
ations are the most disparate regions in the RK and JI
genomes, and are responsible for almost all of the size
difference between the two sequences.
Many positions outside the reiterations differ in the
two HHV-7 sequences, most as nucleotide substitutions
but some as small insertions or deletions. In determining
the origins of these differences, the RK sequence was
examined carefully in these regions, obtaining new data
when necessary in order to exclude errors. Next, inferred
errors in the JI sequence were identified as insertions or
deletions in coding regions that result in frameshifts
causing loss of amino acid sequence similarity to HHV-6.
Only four errors were noted, two in ORF U38 (2-bp dele-
tion at 57,718 and a 1-bp deletion at 57,733) and two in
ORF U53 (1-bp deletion at 81,361 and a 2-bp deletion plus
a 2-bp substitution at 81,380). Each causes a local shift
from and then back into the correct reading frame. In
principle, some of the remaining differences may also
result from errors in the JI sequence. There is, however,
no evidence to support this, and all other disparities
were classified as reflecting genuine strain variation.
The types and distribution of differences are listed in
Table 1. As anticipated, the majority of differences do not
affect coding capacity. Moreover, differences that do
affect coding potential are scattered throughout the ge-
nome, and do not appear to be clustered in particular
genes. This indicates that no small subset of genes has
been demonstrably subject to unusual evolutionary pres-
sures since divergence of the two strains.
McGeoch and Cook (1994) demonstrated that the phy-
logeny of most members of the Alphaherpesvirinae is
similar to that of their hosts. They concluded that these
viruses have cospeciated with their hosts over periods
up to 6 3 107 years, derived a timescale for evolution of
the subfamily, and estimated an overall rate of sequence
change of 1 3 1027 synonymous substitutions per syn-
onymous site per year in the gB gene. This value was
claimed as an order of magnitude estimate only. It was
considered compatible with estimates derived by analy-
ses of herpes simplex virus type 1 isolates from human
populations established over a much shorter period (105
years). On this basis, the presence of 84 synonymous
substitutions in HHV-7 U (which, unlike DR, is not poten-
tially subject to intragenomic homologous recombina-
tion) indicates that the lineages leading to RK and JI
diverged from a common ancestor of the order of 104
years ago. In contrast, HHV-7 and HHV-6 are estimated
to have diverged 5-6 3 107 years ago (D.J. McGeoch,
personal communication).
Genetic content
The criteria used to identify genes in a nucleotide
sequence are to some extent arbitrary and inevitably
TABLE 1
Differences between the Genome Sequences of HHV-7(RK) and (JI)
Type of difference
Genome region
DR U Totala
Synonymous substitution 10 84 104
Nonsynonymous substitution 2 46 50
Multiple substitutionb 1 2 4
Insertion/deletionc 5 11 21
Total 18 143 179
a U plus two copies of DR.
b Two or more consecutive nucleotide substitutions.
c One or a small number of nucleotides.
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lead to false positives and false negatives. This applies
even to criteria that imply numerical exactitude, such as
minimum ORF length. Thus, a prediction of genetic con-
tent actually takes the form of a spectrum of probabilities,
ranging from solid candidates (usually substantial ORFs
with counterparts in other genomes) to marginal possi-
bilities (usually smaller ORFs lacking counterparts). The
effects of different sets of criteria are usually apparent in
the lower reaches of the spectrum. Also, as data become
available, specific factors occasionally have a dominant
effect on individual candidates regardless of other con-
siderations (experimental information on gene expres-
sion, for example).
In evaluating the genetic content of HHV-7 and HHV-6,
we started with the previous predictions of coding ca-
pacity. Primary recognition was given to potential genes
identified as ORFs that encode proteins with sequence
counterparts in the other virus. Since the great majority
of herpesvirus genes have individual polyadenylation
signals close downstream from the ORF or are ex-
pressed as part of a 39 coterminal family of ORFs with a
polyadenylation signal close downstream from the most
39 member, appropriate location of such signals was
also an important factor. ORFs unique to each genome
but substantial in size and possessing polyadenylation
signals were then considered. Similarities to proteins
encoded by other herpesviruses or other organisms,
features diagnostic of membrane proteins, and potential
splicing and transcript mapping data were also taken
into account. Some previously identified ORFs suffer
from combinations of features indicating that they are
less likely to encode proteins: small size, lack of suitable
initiation codons, significant overlap with other genes,
presence of extensive reiterated sequences, absence of
suitable polyadenylation signals, and lack of sequence
similarity to other proteins. We consider that the status of
these ORFs is sufficiently uncertain to exclude them as
candidate genes at present. Codon usage or base pref-
erence analyses were not of strong predictive value in
evaluating genetic content; in any case, they would have
been of limited use for the small ORFs which make up
most of the marginal category.
This rather stringent approach effectively resulted in a
spectrum of probabilities for each virus that is truncated
at its lower margin in comparison with those derived
previously. We are aware that it is biased towards ex-
cluding genes that are present in only one of the two
viruses (false negatives) rather than to inclusion of ORFs
that do not encode proteins (false positives). Neverthe-
less, each candidate ORF was considered carefully in
developing the schemes described below. Thus, we view
the results as closer representations of the genetic con-
tents of HHV-7 and HHV-6 than were previously avail-
able, both in terms of exclusion of marginal ORFs and in
identification of potentially spliced genes (described be-
low). One consequence is that the genetic complements
of HHV-7 and HHV-6 appear more similar than previously
proposed.
The deduced layout of HHV-7 genes is shown in Fig. 1,
and details are listed in Table 2. The nomenclature de-
veloped for HHV-6 and extended to JI was employed for
RK, except that several ORFs potentially expressed by
splicing are identified only by the 59-proximal ORF. Of the
ORFs identified in the JI sequence that are absent from
Fig. 1, parts of DR2, DR7, U5, U16, U17, U17ex, U60, U80,
U89, H6, H8, U98, and U99 now form exons in spliced
genes; U17ex spliced to U16 is termed U17. The remain-
ing JI ORFs lacking counterparts in HHV-6 (H1, H2, H3,
H4, U17a, H5, and H7) are considered unlikely to encode
proteins for reasons listed above. Moreover, H3 and H4
are disrupted by insertions or deletions in RK.
As a result of this analysis, we consider that HHV-7
has 84 different genes, 2 (DR1 and DR6) present twice,
giving a total of 86 genes in the genome. The most
marginal candidate, U24a, is small and poorly con-
served, but encodes a protein containing a highly hydro-
phobic domain in both HHV-7 and HHV-6. All proposed
genes but one have direct HHV-6 counterparts. The ex-
ception, U55B, is a sizeable member of a 39-coterminal
family, and was shown previously to be related to an
adjacent member, U55A. Both genes are thus related to
HHV-6 U55. All proposed HHV-7 genes have candidate
polyadenylation signals near the 39 end of the ORF or
39-coterminal family, as shown in Fig. 1.
Similar criteria applied to the HHV-6 sequence indi-
cate that the genome has 85 different genes (87 total), all
with appropriate polyadenylation signals except U2,
which instead has a CATAAA element. Of the 22 HHV-6
ORFs identified by Gompels et al. (1995) that lack HHV-7
counterparts, only two are strong candidates for encod-
ing complete proteins: U22, a potential membrane gly-
coprotein, and U94, a homologue of the adeno-associ-
ated virus type 2 rep gene. HHV-6 U87 now forms part of
U86, owing to a sequencing error by Nicholas (1994) that
was corrected by Nicholas (1996). Most ORFs lacking
counterparts in HHV-7 (LT1, DR3, DR4, DR5, DR8, LJ1, U1,
U6, U9, U61, U78, U83, U88, U92, U93, and RJ1) are
considered unlikely to encode proteins. U12ex, U96, and
U97 are predicted to form exons in spliced genes.
Where possible, amino acid sequence similarity be-
tween HHV-7 and HHV-6 was also used as a guide to
locating initiation codons and possible splice sites. This
resulted in modifications to the locations of some HHV-7
genes from those reported for JI, and details of these are
incorporated into Table 2. Suggested modifications to the
genes listed by Gompels et al. (1995) are given in Table
3; a few were included in publications that preceded
completion of the HHV-6 sequence or were implied by
Nicholas (1996).
About half of the genes in HHV-7 and HHV-6 have
counterparts in all sequenced mammalian herpesvi-
ruses; these are termed core genes and are highlighted
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TABLE 2
Features of HHV-7(RK) Genes
Genea Strand Startb Stopc Codons IDd Properties
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in Table 2. The previous studies pointed out that most
noncore genes are located towards the genome termini,
and many have counterparts in HCMV (Chee et al., 1990)
or murine cytomegalovirus (MCMV; Rawlinson et al.,
1996). Several of these genes belong to the US22 family,
some members of which appear to be involved in gene
regulation.
Splicing
Drawing largely on data from other herpesviruses (es-
pecially HCMV) and in some cases on transcript map-
ping data, previous work indicated that splicing may
occur in some HHV-6 genes. However, the detailed sit-
uation was unclear. Splice sites were predicted for U66
(Lawrence et al., 1990) and U17, U18, and U20 (Nicholas
and Martin, 1994), and splicing patterns were deduced
from transcript mapping data for U90, U91, and U100
(Schiewe et al., 1994; Pfeiffer et al., 1995). Subsequently,
Gompels et al. (1995) listed sites only for HHV-6 U12 and
U17, with three of the four sites apparently incorrect, as
described below. Nicholas (1996) indicated that splicing
may occur in certain HHV-7 genes, but predicted splice
TABLE 2—Continued
Genea Strand Startb Stopc Codons IDd Properties
a Protein-coding exons (ex) are listed. Genes with counterparts in all mammalian herpesviruses are shaded.
b First exons, from first nucleotide of first complete codon (U7) or initiation codon (other ORFs). Subsequent exons, from first nucleotide.
c To last nucleotide of stop codon or exon.
d Percentage identical amino acid residues to the HHV-6 counterpart as determined by Gap at default values; U23 proteins did not align at these
settings.
e Properties derived from the current analysis and summaries in Gompels et al. (1995), Nicholas (1996), and numerous other herpesvirus genome
sequence papers. For genes with counterparts in all mammalian herpesviruses, the HSV-1 nomenclature is given in square parentheses; where
identification is based on positional data, the HSV-1 gene is shown in italics.
f Immediate early B locus.
g Related to HSV-1 UL50 encoding deoxyuridine triphosphatase, but probably lacking enzymatic function.
h Immediate early A locus.
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sites only for U66 and U17. In reassessing this aspect of
HHV-7 gene organization, we found substantial support
from sequence comparisons for splicing in nine genes in
addition to U66 and U17 (U7, U15, DR1, DR6, U12, U79,
U90, U91, and U100), and were able to predict splicing
patterns.
Appropriate parts of the RK and HHV-6 DNA se-
quences were aligned with conceptual translation prod-
ucts in all six reading frames, and splicing patterns were
identified by visual comparison of the amino acid se-
quences at corresponding locations in the two genomes.
In instances where similarity between potential protein-
TABLE 3
Proposed Modifications to HHV-6A(U1102) Genes
Genea Strand Startb Stopc Codons Reason for change
DR1 ex1 1 501 759 689 Putative splicing; exon 1 starts at 500
ex2 843 2653
DR6 ex1 1 4725 5028 395 Putative splicing
ex2 5837 6720
U7 ex1 2 15921 14948 .872 Putative splicing; exon 1 starts at 15923
ex2 14858 13214
U12 ex1 1 21680 21712 351 Correction of splice sites
ex2 21790 22812
U14 1 23331 25145 604 59 truncationd
U15 ex1 2 25992 25676 191 Putative splicing
ex2 25602 25530
ex3 25364 25179
U17 ex1 2 27349 27121 334 Definition of splice sites
ex2 27034 26259
U24A 2 35847 35674 57 Not previously identified
U27 2 38903 37797 368 59 truncation
U30 1 42325 45132 935 59 truncation
U44 1 73470 74087 205 59 truncation
U47 2 77768 75912 618 59 truncation
U53.5 1 85133 85867 244 Definition of coding region
U66 ex1 2 102486 101614 666 Definition of splice sites
ex2 98415 97288
U67 1 102485 103519 344 59 truncation
U76 2 115257 113317 646 59 truncation
U79 ex1 1 120164 120794 474 Definition of splice sites
ex2 120891 121087
ex3 121170 121766
U86 2 130044 125989 1351 Error correction
U90 ex1 2 136112 136054 941 Definition of splice sites; exon 1 starts at 136150
ex2 135965 135772
ex3 135664 133092
U91 ex1 1 136267 136477 153 Definition of splice sites
ex2 136580 136830
U100 ex1 2 150282 149873 656 Definition of splice sites; exon 1 starts at 150295
ex2 149771 149490
ex3 149081 148746
ex4 148628 148551
ex5 148454 148347
ex6 148255 148142
ex7 148055 147895
ex8 147383 147374
ex9 147223 147095
ex10 146984 146642
DR1 ex1 1 151735 151993 689 Putative splicing; exon 1 starts at 151734
ex2 152077 153887
DR6 ex1 1 155959 156262 395 Putative splicing
ex2 157071 157954
a Protein-coding exons (ex) are listed. Coordinates include an extra G residue at 128132 (in U86) as indicated by Nicholas (1996).
b First exons, from first nucleotide of first complete codon (U7) or initiation codon (other ORFs). Subsequent exons, from first nucleotide.
c To last nucleotide of stop codon or exon.
d As determined by aligning N-terminal regions of homologous proteins.
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coding regions extended upstream from the first initia-
tion codon or did not extend to the stop codon, se-
quences were analysed for the presence of consensus
donor and acceptor sites. In general, splicing was pro-
posed when candidate sites were located similarly in the
two genomes, so that two exons could in principle be
joined in the same register and express the conserved,
and not the nonconserved, polypeptide regions. This
process was not taken to the same level of detail for the
entire genome, but only for regions in which splicing had
been demonstrated experimentally, for regions in which
splicing was suspected, or for regions lacking obvious
coding potential.
Table 4 summarizes splice sites proposed from the
analysis, and lists JI ORFs forming exons in spliced
genes. The evidence for splicing in U66, U7, and U15 is
shown in Fig. 2. U66 is shown as an example of a gene
that is almost certainly spliced at sites which have been
predicted previously. It has counterparts in all herpesvi-
ruses in which the splice sites and coding potential are
strongly conserved, and has been shown experimentally
to be spliced in herpes simplex virus type 1 (Dolan et al.,
1991). Figure 2 shows that significant amino acid se-
quence similarity does not extend beyond the proposed
splice sites into the intron, that the sites are in the same
register in HHV-7 and HHV-6, and that the exons are
joined appropriately.
Figure 2 also shows evidence for U7 and U15, neither
of which was previously suspected of being spliced. Two
substantial ORFs in HHV-6, U5, and U7 are represented
in JI by a single, apparently fused ORF (U5/7). Observing
the presence of US22 motifs in the U7 domain, Nicholas
(1996) speculated that the fused protein might have a
unique regulatory function in HHV-7. However, the data in
Fig. 2 suggest that ORFs U7 and U5 form two exons of a
single gene in both genomes (U7 in Fig. 1 and Table 2).
Thus, in this scheme U7 is flanked at its 59 end by U8
which, like exon 1, contains US22 motifs, and at its 39 end
TABLE 4
Predicted Splice Sites in the HHV-7 and HHV-6 Genomes
RK ORF JI ORF HHV-7 acceptor HHV-7 donor HHV-6 acceptor HHV-6 donor
consensus YYYYYYYYYYYNYAGG MAGGTRAGT YYYYYYYYYYYNYAGG MAGGTRAGT
DR1 exon 1 DR1 TCTCTTCTATCACAGA CATGTAAGC CTATTCTTACTCTAGG TATGTGAGT
exon 2 DR2 TTTGCTCTATCGCAGG None TTTGGTTTCCCTCAGG None
DR6 exon 1 DR6 None GCGGTGAGT None GCGGTGAGT
exon 2 DR7 TCTACATCCCGGCAGC None CGCGTCCCATCACAGC None
U7 exon 1 U7 AAGTTAATTTTGCAGA TAGGTATGT TTATGTTTCAAACAGA CAGGTGGGT
exon 2 U5 GATGTTCTTTTTCAGA None TTTTTCTTACAACAGG None
U12 exon 1 — None CTGGTATGA None CTGGTAAGT
exon 2 U12 AACTTTTTTTCACAGC None CAATATCTTTAATAGC None
U15 exon 1 U15 None ACGGTGAGT None AAGGTGGGT
exon 2 — CTCTTTTATTTTCAGG GCGGTAAGA GTTTTTCTTTTACAGG GCGGTGAGT
exon 3 — TTTTTTTTTCTTTAGT None TGTTTTTTTTTTAGT None
U17 exon 1 U17 None TATGTAAGT None TGTGTAAGT
exon 2 U16 TTGTTGTTTTCATAGG None TTCCTTTTAAACAAGG None
U66 exon 1 U66 None CACGTAAGT None CACGTAAGT
exon 2 U60 TCATTTTCTTCTCAGA None TCATTCCCCTCTCAGA None
U79 exon 1 U79 None AAGGTTAGT None ATGGTAAAT
exon 2 H6 AACATGTTTTCTTAGA CAGGTGGGT TTGTTGCAATTTCAGA CAGGTGGGT
exon 3 U80 GTTTCTTTCTTTTAGG None ATCTTTTTATTTTAGG None
U90 exon 1 — GGTTTGTTATTGTAGG TGAGTAGGT TTCATTGGCTATCAGC AGAGTAAGT
exon 2 U90 TAAATTTTATTACAGA CAGGTATTT TATTTATACTTACAGC CTGGTAAGT
exon 3 U89 TTCTTTAAATTCTAGC None TCTTTTACATCCTAGC None
U91 exon 1 U91 None CAGGTTTGT None CTGGTTAGT
exon 2 — TATTTTTTCTTGTAGA None ATGGTTTGTTTTTAGA None
U100 exon 1 U100 AAAATCTCTTCGCAGA ACAGTAAGT CGAAATTTTCACAAGA ACGGTAAGG
exon 2 U99 TTTAATTCTTCTAAGG ATGGTAAGC TTTAATTTATCGCAGC ATGGTGAGT
exon 3 U98 GTACCCGCTTATTAGT AGTGTAAGT ATTTATTCACTCAAGT CGTGTAAGT
exon 4 — TATTTTTTTTTTTAGA AATGTAAGA TTCGTTTTTTGTCAGG ACTGTAAGT
exon 5 — AATTGTGTTTCGCAGT CAGGTAAAT TTATGTTTCTAACAGA ACGGTGAGT
exon 6 — GCTTCTTCATCCTAGA TTGGTAATT TCCGGTTATGCACAGC ATGGTGAGC
exon 7 — TTTTTTTCATACCAGC ACAGTGGAA TTTCTTAATTTGCAGC AGGGTGGGC
exon 8 — TTTTTTTAATTCTAGC CATGTGAGT TTTCGACCTGCCTAGAa AATGTAAGT
exon 9 — ATTTCTCGTTCGCAGC CAGGTGAGC TTGATATTTGTTCAGT TAGGTATTA
exon 10 H8 CATTTTCTCTTTTAGT None TGTTTTTTTTTTAAGT None
a Another acceptor site (GCTACCGCTTTTTAGC) is located farther upstream. It could extend coding similarity between HHV-7 and HHV-6 exon 8,
but it is in an inappropriate reading frame.
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by U4, which is related to exon 2 (Table 2). The analysis
also gave a somewhat weaker indication that U7 may be
spliced at its 59 end, as amino acid sequence similarity
extends upstream from the previously proposed HHV-7
initiation codon. We were unable, however, to identify an
upstream coding exon. U8 is a possibility, but this ar-
FIG. 2. Sequence-derived evidence for splicing in the coding regions of HHV-7 and HHV-6 genes U66, U7, and U15. Each part shows the relevant
DNA sequence with appropriate conceptual translation products aligned from left to right. For U66, amino acid sequences extending to the stop codon
defining the 39 end of the upstream ORF and from the stop codon (hyphen) defining the 59 end of the downstream ORF are shown. The DNA
sequences begin and end at arbitrary points in the ORFs, and conserved amino acid residues are underlined. The proposed intron sequence (flanked
by splice donor and acceptor sites as listed in Table 4) is shown in lower case in the DNA sequence, and amino acid residues excluded from the
protein predicted to be expressed via splicing are also shown in lower case. The dots indicate a sizeable region of the intron that is not shown. For
U7, the two ORFs are in the same frame in HHV-7 (and therefore are not divided by stop codons), but overlap in HHV-6. Double underlining indicates
the initiation codon previously assigned to the downstream HHV-6 ORF (U5). The DNA sequences for U15 contain three exons and two introns, and
extend from the proposed initiation codon in exon 1 to the stop codon in exon 3.
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rangement would result in a protein with an unusual
structure (i.e., two contiguous US22 domains). Figure 2
also strongly supports the presence of three exons in
U15. Amino acid sequence conservation is high, and
splice sites are located identically in the two genomes.
Splicing events were previously suspected of occur-
ring in five genes for which experimental data were not
available: DR1, DR6, U12, U17, and U79. It had been
reported for HHV-6 and JI that DR1 is related to DR6 and
DR2 to DR7, and that each ORF contains motifs charac-
teristic of the US22 gene family. Nicholas (1996) noted
that JI DR1 and DR2 lack suitable initiation codons, in
contrast to their HHV-6 counterparts, speculated that
these might be supplied by splicing, and commented that
splicing of DR1 to DR2 and DR6 to DR7 would result in
proteins containing the US22 motifs in their usual order.
Our analysis supports the view that DR1 and DR2 form
exons in a spliced gene (DR1 in Table 2) and that DR1
may be spliced at its 59 end to a noncoding exon, but
indicates that DR1 supplies its own initiation codon.
Similarly, we agree that DR6 and DR7 may be spliced
(DR6 in Table 2), and found no evidence for splicing at
FIG. 2—Continued
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the 59 end of DR6. The donor and acceptor sites pro-
posed for HHV-6 U12 in Table 4 differ from those of
Gompels et al. (1995); splicing was not proposed for the
JI counterpart by Nicholas (1996). With regard to U17, our
analysis supports the previous assignments of Nicholas
and Martin (1994) and Nicholas (1996).
Schiewe et al. (1994) derived detailed splicing patterns
for HHV-6 U90 and U91 from transcript mapping and
cDNA cloning experiments. Immediate early gene U90
contains three exons, and gene U91 contains two. The
HHV-7 and HHV-6 U91 proteins contain two pronounced
hydrophobic regions (one near the N terminus and the
other about two-thirds through the protein) and therefore
are likely to be associated with membranes. Both have a
single consensus site for N-linked glycosylation in the
region between the hydrophobic domains, and the
HHV-7 protein has two additional sites near the C termi-
nus. Evidence that U91 encodes putative membrane gly-
coproteins in HHV-7 and HHV-6 has not been reported
previously.
The region at the right end of U contains several short
ORFs which have been shown by sequencing a cDNA
clone to be expressed in HHV-6 as a multiply spliced
mRNA encoding the virion envelope glycoprotein gp105
(Pfeiffer et al., 1995). The mRNA contains ten coding
exons (here termed exons 1–10), five of which were
identified as ORFs in the HHV-6 sequence, plus two
upstream noncoding exons. Nicholas (1996) described
four ORFs in this part of the JI genome, but was unable
to deduce a splicing pattern. Our attempt to decipher the
arrangement of the RK gene is given in Table 2. There is
less certainty at some points because polypeptides en-
coded by exons 1 and 10 are poorly conserved. It was
also necessary to propose that the exon 8 and 10 ac-
ceptor sites are not similarly located in HHV-7 and
HHV-6, although they are in the same register in each
genome. Indeed, it is curious that use of an alternative
acceptor site for HHV-6 exon 8 located upstream from
the site mapped by Pfeiffer et al. (1995) could signifi-
cantly extend the similarity with the HHV-7 exon 8
polypeptide; details are given in Table 4. The site is in an
incorrect reading frame, however, so this point remains
unresolved. The status of upstream noncoding exons is
unknown.
Various other possible splice sites were noted during
the analysis, including those supporting splicing of U12
exon 1 to U13 and of the 39 end of U19 to an unidentified
downstream exon. The evidence in these instances was
weak, however, and the sites must be considered much
more speculative than those listed in Table 4. In a few
regions where splicing might reasonably be expected,
such as that containing U24 and U24a, no evidence was
forthcoming.
All spliced genes proposed above except U66 are
noncore genes, although some have counterparts in
HCMV and MCMV. Indeed, it was the evidence for splic-
ing in certain HCMV genes that led to initial suspicions
of splicing in the HHV-7 and HHV-6 counterparts (e.g.,
U17). Some of the putatively spliced genes in HHV-7 and
HHV-6 have counterparts in HCMV and MCMV that are
not known to be spliced (e.g., U7) or are spliced differ-
ently (e.g., U79). The evolutionary distances involved,
however, preclude easy identification of corresponding
splicing patterns in the HCMV and MCMV genes. Also,
database searches conducted using proteins encoded
by putative spliced mRNAs did not reveal significant
similarities to proteins other than those reported previ-
ously.
The degree of confidence in the splicing patterns pro-
posed above rests on the level of amino acid sequence
conservation, the presence of potential splice sites in
corresponding locations in both genomes, and, where
available, on experimental corroboration. In summary,
we consider that each of the proposed HHV-7 splice
sites in Table 4 is a strong candidate worthy of experi-
mental investigation. Nevertheless, complex splicing
patterns, use of alternative splice sites, long-range splic-
ing, and involvement of noncoding exons are very likely
to have escaped detection. Consequently, we speculate
that splicing is probably more common in HHV-7 and
HHV-6 than is suggested from our analysis.
MATERIALS AND METHODS
Preparation and purification of DNA
Human cord blood mononuclear cells were treated
with 10 mg/ml phytohemagglutinin for 2 days in RPMI
1640 medium containing 10% (v/v) fetal calf serum, 50
mg/ml gentamycin (Frenkel et al., 1990; Berneman et al.,
1992b; Black and Pellett, 1993). The cells were then
incubated for 2 h at 37°C with concentrated aliquots of
HHV-7(RK). Following adsorption, the cells were diluted
with medium to 106 cells/ml (approximately 300 ml total),
and incubated further at 37° (Frenkel and Rapaport,
1995). The typical CPE of HHV-7 infection, characterized
by ballooning of cells and the appearance of limited
syncytia, became evident in the culture. At 14 days after
infection, cells were harvested by centrifugation, rinsed
in phosphate-buffered saline and pelleted once more.
The cells were resuspended in 10 mM Tris–HCl, pH 7.5,
10 mM NaCl, 1.5 mM MgCl2, 0.6% (v/v) Nonidet P40,
Dounce homogenized, and separated into nuclear and
cytoplasmic fractions by centrifugation. The fractions
were treated with 0.5% (w/v) sodium deoxycholate and
incubated with 50 mg/ml DNase I and 10 mg/ml RNase A,
and capsids were prepared by density centrifugation on
sucrose gradients as described by Gibson and Roizman
(1972) and Vlazny et al. (1982). DNA was extracted from
capsids as described by Di Luca et al. (1990).
In order to confirm the presence of HHV-7 genomic
DNA and to check for contamination with smaller frag-
ments, DNA preparations were assessed by agarose gel
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electrophoresis of untreated material and material di-
gested by restriction endonucleases. Genomic DNA was
precipitated from one sample obtained from the cyto-
plasmic fraction by incubating with 8% (w/v) polyethylene
glycol 6000, 1 M NaCl for 16 h at 0°C. The DNA was
pelleted by centrifugation for 5 min at 11,000g in a mi-
crocentrifuge, washed twice with 70% ethanol, air dried,
and resuspended in a small volume of 10 mM Tris–HCl,
pH 7.5, 1 mM EDTA.
DNA sequencing and sequence analysis
Random DNA fragments were generated by sonication
of purified genomic DNA. Fragments 400–700 bp in size
were excised from an agarose gel, purified using a
Geneclean II kit (Bio 101, Inc.), treated with T4 DNA
polymerase in the presence of the four deoxynucleoside
triphosphates, and cloned into the SmaI site of bacterio-
phage M13mp19. DNA templates were prepared from
recombinant plaques produced by transfection of ligated
DNA into Escherichia coli DH5aF9 (Life Technologies
Ltd.), and sequenced by the dideoxynucleotide chain
termination technology (Sanger et al., 1977) as described
by Davison (1991). Autoradiographs were read using a
Summagraphics digitizer and the database was com-
piled using Staden’s sequence analysis program (Sta-
den, 1987). The sequence was edited by reference to
autoradiographs and analysed using programs from the
Wisconsin Package Version 9.0, Genetics Computer
Group (Madison, WI). The sequence has been deposited
with the GenBank Data Library under Accession No.
AF037218.
Sequence comparisons were carried out using the
sequences of HHV-7(RK), HHV-7(JI) (Nicholas, 1996; Ac-
cession No. U43400, Version 5), and HHV-6A(U1102)
(Gompels et al., 1995; Accession No. X83413, Version 16).
For certain comparisons, published sequences from
other HHV-6A strains were also utilized.
ACKNOWLEDGMENTS
We are grateful to Duncan McGeoch for criticizing the manuscript.
We thank the Israel Academy of Science, the Israel Ministry of Health,
and the Wolfson Foundation for their support of this research.
REFERENCES
Berneman, Z. N., Ablashi, D. V., Li, G., Eger-Fletcher, M., Reitz, M. S., Jr.,
Hung, C.-L., Brus, I., Komaroff, A. L., and Gallo, R. C. (1992a). Human
herpesvirus 7 is a T-lymphotropic virus and is related to, but signif-
icantly different from, human herpesvirus 6 and human cytomegalo-
virus. Proc. Natl. Acad. Sci. USA 89, 10552–10556.
Berneman, Z. N., Gallo, R. C., Ablashi, D. V., Frenkel, N., Katsafanas, G.,
Kramarsky, B., and Brus, I. (1992b). Human herpesvirus 7 (HHV-7)
strain JI: Independent confirmation of HHV-7. J. Infect. Dis. 166,
690–691.
Black, J. B., and Pellett, P. E. (1993). Human herpesvirus 7. Rev. Med.
Virol. 3, 217–223.
Chee, M. S., Bankier, A. T., Beck, S., Bohni, R., Brown, C. M., Cerny, R.,
Horsnell, T., Hutchison, C. A., III, Kouzarides, T., Martignetti, J. A.,
Preddie, E., Satchwell, S. C., Tomlinson, P., Weston, K. M., and Barrell,
B. G. (1990). Analysis of the protein-coding content of the sequence
of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immu-
nol. 154, 125–169.
Davison, A. J. (1991). Experience in shotgun sequencing a 134 kilobase
pair DNA molecule. DNA Sequence 1, 389–394.
Di Luca, D., Katsafanas, G., Schirmer, E. C., Balachandran, N., and
Frenkel, N. (1990). The replication of viral and cellular DNA in human
herpesvirus 6-infected cells. Virology 175, 199–210.
Dolan, A., Arbuckle, M., and McGeoch, D. J. (1991). Sequence analysis
of the splice junction in the transcript of herpes simplex virus type 1
gene UL15. Virus Res. 20, 97–104.
Frenkel, N., Schirmer, E. C., Wyatt, L. S., Katsafanas, G., Roffman, E.,
Danovich, R. M., and June, C. H. (1990). Isolation of a new herpes-
virus from human CD41 T cells. Proc. Natl. Acad. Sci. USA 87,
748–752.
Frenkel, N., and Rapaport, D. (1995). Detection of human herpesviruses
6 and 7 by PCR. In ‘‘PCR: Protocols for Diagnosis of Human and
Animal Virus Diseases’’ (Y. Becker and G. Davis, Eds.), pp. 243–251.
Springer, Berlin.
Frenkel, N., and Roffman, E. (1996). Human herpesvirus 7. In ‘‘Fields
Virology’’ (B.N. Fields, D.M. Knipe, and P.M. Howley, Eds.), 3rd ed., pp.
2609–2622. Lippincott-Raven, Philadelphia.
Gibson, W., and Roizman, B. (1972). Proteins specified by herpes sim-
plex virus. VIII. Characterization and composition of multiple capsid
forms of subtypes 1 and 2. J. Virol. 10, 1044–1052.
Gompels, U. A., Nicholas, J., Lawrence, G., Jones, M., Thomson, B. J.,
Martin, M. E. D., Efstathiou, S., Craxton, M., and Macaulay, H. A.
(1995). The DNA sequence of human herpesvirus-6: Structure, cod-
ing content, and genome evolution. Virology 209, 29–51.
Lawrence, G. L., Chee, M., Craxton, M. A., Gompels, U. A., Honess,
R. W., and Barrell, B. G. (1990). Human herpesvirus 6 is closely
related to human cytomegalovirus. J. Virol. 64, 287–299.
McGeoch, D. J., and Cook, S. (1994). Molecular phylogeny of the
Alphaherpesvirinae subfamily and a proposed evolutionary time-
scale. J. Mol. Biol. 238, 9–22.
Nicholas, J. (1994). Nucleotide sequence analysis of a 21-kbp region of
the genome of human herpesvirus-6 containing homologues of hu-
man cytomegalovirus major immediate-early and replication genes.
Virology 204, 738–750.
Nicholas, J. (1996). Determination and analysis of the complete nucle-
otide sequence of human herpesvirus 7. J. Virol. 70, 5975–5989.
Nicholas, J., and Martin, M. E. D. (1994). Nucleotide sequence analysis
of a 38.5-kilobase-pair region of the genome of human herpesvirus 6
encoding human cytomegalovirus immediate-early gene homologs
and transactivating functions. J. Virol. 68, 597–610.
Okuno, T., Takahashi, K., Balachandra, K., Shiraki, K., Yamanishi, K.,
Takahashi, M., and Baba, K. (1989). Seroepidemiology of human
herpesvirus 6 infection in normal children and adults. J. Clin. Micro-
biol. 27, 651–653.
Pfeiffer, B., Thomson, B., and Chandran, B. (1995). Identification and
characterization of a cDNA derived from multiple splicing that en-
codes envelope glycoprotein gp105 of human herpesvirus 6. J. Virol.
69, 3490–3500.
Rawlinson, W. D., Farrell, H. E., and Barrell, B. G. (1996). Analysis of the
complete DNA sequence of murine cytomegalovirus. J. Virol. 70,
8833–8849.
Roizman, B., Carmichael, L. E., Deinhardt, F., de-The, G., Nahmias, A. J.,
Plowright, W., Rapp, F., Sheldrick, P., Takahashi, M., and Wolf, K.
(1981). Herpesviridae: Definition, provisional nomenclature, and tax-
onomy. Intervirology 16, 201–217.
Ruvulo, V. R., Berneman, Z., Seccheiro, P., and Nicholas, J. (1996).
Cloning, restriction endonuclease mapping and partial sequence
analysis of the genome of human herpesvirus 7 strain JI. J. Gen. Virol.
77, 1901–1912.
Sanger, F., Nicklen, S., and Coulson, A. R. (1977). DNA sequencing with
131HHV-7 RK SEQUENCE
chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463–
5467.
Schiewe, U., Neipel, F., Schreiner, D., and Fleckenstein, B. (1994).
Structure and transcription of an immediate-early region in the hu-
man herpesvirus 6 genome. J. Virol. 68, 2978–2985.
Secchiero, P., Nicholas, J., Deng, H., Xiaopeng, T., van Loon, N., Ruvulo,
V. R., Berneman, Z. N., Reitz, M. S. Jr., and Dewhurst, S. (1995).
Identification of human telomeric repeat motifs at the genome termini
of human herpesvirus 7: Structural analysis and heterogeneity. J. Vi-
rol. 69, 8041–8045.
Singer, O., and Frenkel, N. (1997). Human herpesvirus 7 (HHV-7) DNA:
Analyses of clones spanning the entire genome. Arch. Virol. 142,
287–303.
Staden, R. (1987). Computer handling of DNA sequencing projects. In
‘‘Nucleic Acid and Protein Sequence Analysis: A Practical Approach’’
(M. J. Bishop, and C. J. Rawlings, Eds.), pp. 173–217. IRL Press,
Oxford.
Tanaka, K., Kondo, T., Torigoe, S., Okada, S., Mukai, T., and Yamanishi,
K. (1994). Human herpesvirus 7: Another causal agent for roseola
(exanthem subitum). J. Pediatr. 125, 1–5.
van Loon, N., Dykes, C., Deng, H., Dominguez, G., Nicholas, J., and
Dewhurst, S. (1997). Identification and analysis of a lytic-phase
origin of DNA replication in human herpesvirus 7. J. Virol. 71,
3279–3284.
Vlazny, D. A., Kwong, A., and Frenkel, N. (1982). Site-specific cleavage/
packaging of herpes simplex virus DNA and the selective maturation
of nucleocapsids containing full-length viral DNA. Proc. Natl. Acad.
Sci. USA 79, 1423–1427.
Wyatt, L. S., Rodriguez, W. J., Balachandran, N., and Frenkel, N. (1991).
Human herpesvirus 7: Antigenic properties and prevalence in chil-
dren and adults. J. Virol. 65, 6260–6265.
Yamanishi, K., Okuno, T., Shiraki, K., Takahashi, M., Kondo, T., Asano, Y.,
and Kurata, T. (1988). Identification of human herpesvirus-6 as a
causal agent for exanthem subitum. Lancet i, 1065–1067.
132 MEGAW ET AL.
